143 related articles for article (PubMed ID: 30925760)
1. Contribution of Inflammatory Cytokine Interleukin-18 Genotypes to Renal Cell Carcinoma.
Chang WS; Shen TC; Yeh WL; Yu CC; Lin HY; Wu HC; Tsai CW; Bau DT
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925760
[TBL] [Abstract][Full Text] [Related]
2. Associations of Matrix Metalloproteinase-8 Genotypes to Renal Cell Carcinoma in Taiwan.
Liao CH; Chien WC; Chang SY; Lin YH; Wang YC; Huang WC; Mong MC; Yang YC; Wu WT; Chen JC; Chang CH; Tsai CW; Bau DT; Chang WS
Anticancer Res; 2024 May; 44(5):1931-1938. PubMed ID: 38677743
[TBL] [Abstract][Full Text] [Related]
3. Association of caveolin-1 genotypes with renal cell carcinoma risk in Taiwan.
Chang WS; Tsai CW; Wang SM; Wang SW; Wu HC; Ji HX; Lin CH; Wang ZH; Chou JC; Bau DT; Wang PS
Chin J Physiol; 2014 Aug; 57(4):220-6. PubMed ID: 25246063
[TBL] [Abstract][Full Text] [Related]
4. The Role of IL-10 Promoter Polymorphisms in Renal Cell Carcinoma.
Chang WS; Liao CH; Tsai CW; Hu PS; Wu HC; Hsu SW; Ji HX; Hsiao CL; Bau DT
Anticancer Res; 2016 May; 36(5):2205-9. PubMed ID: 27127124
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.
Lin Y; Yuan Q; Qian F; Qin C; Cao Q; Wang M; Chu H; Zhang Z
Gene; 2019 Feb; 685():242-247. PubMed ID: 30472377
[TBL] [Abstract][Full Text] [Related]
6. Association of IL-4 -590 T>C polymorphism and risk of renal cell carcinoma in a Chinese population.
Zhu J; Ju X; Yan F; Qin C; Wang M; Ding Q; Zhang Z; Yin C
Int J Immunogenet; 2010 Dec; 37(6):459-65. PubMed ID: 20618516
[TBL] [Abstract][Full Text] [Related]
7. Impact of interleukin-18 polymorphisms-607 and -137 on clinical characteristics of renal cell carcinoma patients.
Sáenz-López P; Carretero R; Vazquez F; Martin J; Sánchez E; Tallada M; Garrido F; Cózar JM; Ruiz-Cabello F
Hum Immunol; 2010 Mar; 71(3):309-13. PubMed ID: 19961892
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma.
Chu H; Wang M; Yan F; Zhong D; Shi D; Ma L; Pan X; Qin C; Yin C; Zhang Z
Ann Oncol; 2012 Aug; 23(8):2114-2121. PubMed ID: 22317767
[TBL] [Abstract][Full Text] [Related]
9. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
[TBL] [Abstract][Full Text] [Related]
10. IL-16 polymorphism and risk of renal cell carcinoma: association in a Chinese population.
Zhu J; Qin C; Yan F; Wang M; Ding Q; Zhang Z; Yin C
Int J Urol; 2010 Aug; 17(8):700-7. PubMed ID: 20529140
[TBL] [Abstract][Full Text] [Related]
11. Combined effects of DNA methyltransferase 1 and 3A polymorphisms and urinary total arsenic levels on the risk for clear cell renal cell carcinoma.
Yang SM; Huang CY; Shiue HS; Pu YS; Hsieh YH; Chen WJ; Lin YC; Hsueh YM
Toxicol Appl Pharmacol; 2016 Aug; 305():103-110. PubMed ID: 27292127
[TBL] [Abstract][Full Text] [Related]
12. The role of functional polymorphisms of cyclooxygenase 2 in renal cell carcinoma.
Chang WS; Liao CH; Miao CE; Wu HC; Hou LL; Hsiao CL; Ji HX; Tsai CW; Bau DT
Anticancer Res; 2014 Oct; 34(10):5481-6. PubMed ID: 25275044
[TBL] [Abstract][Full Text] [Related]
13. Germline genetic variations at 11q13 and 12p11 locus modulate age at onset for renal cell carcinoma.
Audenet F; Cancel-Tassin G; Bigot P; Audouin M; Gaffory C; Ondet V; Thibault F; Auribault K; Gazut S; Benhabiles N; Azzouzi AR; Méjean A; Rouprêt M; Cussenot O
J Urol; 2014 Feb; 191(2):487-92. PubMed ID: 23911636
[TBL] [Abstract][Full Text] [Related]
14. The TERT locus genotypes of rs2736100-CC/CA and rs2736098-AA predict shorter survival in renal cell carcinoma.
Ma R; Liu C; Lu M; Yuan X; Cheng G; Kong F; Lu J; Strååt K; Björkholm M; Ma L; Xu D
Urol Oncol; 2019 May; 37(5):301.e1-301.e10. PubMed ID: 30738744
[TBL] [Abstract][Full Text] [Related]
15. Contribution of Interleukin-4 Genotypes to Lung Cancer Risk in Taiwan.
Chang WS; Wang SC; Chuang CL; Ji HX; Hsiao CL; Hsu CM; Tsai CW; Liu SP; Hsu PC; Lo YL; Bau DT
Anticancer Res; 2015 Nov; 35(11):6297-301. PubMed ID: 26504066
[TBL] [Abstract][Full Text] [Related]
16. Effect of a functional polymorphism in the pre-miR-146a gene on the risk and prognosis of renal cell carcinoma.
Huang Z; Lu Z; Tian J; Wang G; Gao Z
Mol Med Rep; 2015 Nov; 12(5):6997-7004. PubMed ID: 26323945
[TBL] [Abstract][Full Text] [Related]
17. Impacts of Matrix Metalloproteinase 9 Genotypes on Renal Cell Carcinoma.
Liao CH; Tsai CL; Chang SY; Lin YH; Wang YC; Huang WC; Mong MC; Yang YC; Wu WT; Chen JC; Tsai CW; Bau DT; Chang WS
In Vivo; 2023; 37(6):2452-2458. PubMed ID: 37905646
[TBL] [Abstract][Full Text] [Related]
18. GNAS1 (Gαs) gene T393C polymorphism and renal cell carcinoma risk in a North Indian population: a case-control study.
Arjumand W; Ahmad ST; Nafees S; Ali N; Rashid S; Seth A; Sultana S
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1062-6. PubMed ID: 22931242
[TBL] [Abstract][Full Text] [Related]
19. High incidence of CTLA-4 AA (CT60) polymorphism in renal cell cancer.
Cozar JM; Romero JM; Aptsiauri N; Vazquez F; Vilchez JR; Tallada M; Garrido F; Ruiz-Cabello F
Hum Immunol; 2007 Aug; 68(8):698-704. PubMed ID: 17678726
[TBL] [Abstract][Full Text] [Related]
20. Alcohol consumption, variability in alcohol dehydrogenase genes and risk of renal cell carcinoma.
Antwi SO; Eckel-Passow JE; Diehl ND; Serie DJ; Custer KM; Wu KJ; Cheville JC; Thiel DD; Leibovich BC; Parker AS
Int J Cancer; 2018 Feb; 142(4):747-756. PubMed ID: 29023769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]